The Seneca Managed Storage EIS Fund

An alternative investment fund specialising in EIS qualifying investment into managed storage facilities


Welcome

The Seneca Managed Storage EIS Fund provides investors with the ability to invest in a number of managed storage facilities whilst benefiting from both the tax reliefs available under EIS and the underlying asset value represented by the freehold or long leasehold storage sites.

The Seneca EIS Portfolio Service is a compelling investment option which combines the significant tax benefits available under the Enterprise Investment Scheme with the potential for attractive returns. We do not factor tax reliefs into our targeted investment returns and consider each opportunity on its merit regardless of the tax reliefs available. We offer a discretionary investment management service where the shares are held by a nominee of our independent custodian to the investors order.

 


Read further

Our EIS Brochures and Application forms are now available to download.

The Seneca EIS Portfolio Service


The Seneca Managed Storage EIS Fund 2


Live Portfolio

A Selection from our EIS Investment Portfolio

Investment Approach Image

Investment Approach

Targeting more established and stable businesses with good growth potential is central to our investment strategy

Read More

Charges Image

Charges

Our EIS portfolio charging structure is low and designed to align Seneca to our Investors Objectives

 Read More

Key Features Image

Key Features

Enterprise Investment Schemes grant generous tax benefits in return for providing equity funding to qualifying businesses

 Read More

Risk Factors Image

Risk Factors

You should not invest in this product unless you have thought carefully about whether you can afford it, and whether it is right for you

Read more


Unrivalled Experience

Our team brings together decades of success in providing investment solutions and success for investors

Latest News

March 28th 2017

Evgen granted US patent

Evgen Pharma PLC has been granted a patent by the US Patent & Trademark Office covering its lead product, SFX-01. Evgen Pharma said the patent extends and reinforces the intellectual property in relation to sulforaphane, the naturally occurring compound on...

Read More

Acceleris Tweets

Norman - "regional funds gives you scale, someone to bounce ideas off and gives your business the best chance of success"

The Panel takes their seats - the topic is BIG - 'How will the Northern Powerhouse funds help businesses shift from… twitter.com/i/web/status/84668…

Looking forward to our CEO Norman Molyneux taking part in the next panel event at pic.twitter.com/07XSPA1yOS

Seneca Tweets

Seneca, & organise a 318km charity challenge to raise funds for twitter.com/i/web/status/84166…


Warning

This website makes reference to the previous rounds of investments made by Seneca Partners on behalf of certain investors within the Seneca EIS Portfolio Service. The rationale for the investment may no longer be valid. Under no circumstances should you take this information as a recommendation by Seneca Partners for you to invest in the Service or in any of the companies listed above.

Get in touch

For administrative and shareholder queries, please contact the Seneca EIS Team

For sales or other general queries, please contact the Seneca EIS Team or LGBR Capital


Newsletter Sign Up


Stay Social